Farms.com Home   News

Cwt Supports 138.2 Million Pounds Of Dairy Exports In 2022

Year-end tallies indicate that Cooperatives Working Together (CWT)-assisted sales rose in 2022, as the program did its part in supporting a record year for U.S. dairy exports.

Member cooperatives in 2022 secured 695 contracts, adding 98.0 million pounds of American-type cheeses, 657,000 pounds of butter, 30.7 million pounds of whole milk powder and 8.8 million pounds of cream cheese to CWT-assisted sales. In milk equivalent, this is equal to 1.212 billion pounds of milk on a milkfat basis. On a product volume basis, this is equal to 138.2 million pounds – up 6% (+7.9 million pounds) from 2021. Product destinations include Asia, Central America, the Caribbean, Europe, Middle East-North Africa, Oceania, and South America.

CWT provides a means to move domestic dairy products to overseas markets by helping to overcome U.S. dairy’s trade disadvantages supporting dairy-product exports critical to the viability of dairy farmers and their cooperatives across the country. Whether or not a cooperative is actively engaged in exporting cheese, butter, anhydrous milkfat, cream cheese, or whole milk powder, moving products into world markets is essential.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.